A new Covid-19 vaccine has been given approval for use in the UK. Nuvaxovid has been developed by Novavax.
This is Care Radio, I’m Matt Rosser keeping you up to date with news that a new Covid-19 vaccine has been given approval for use in the UK. Nuvaxovid has been developed by Novavax and is the fifth vaccine to be approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) after two clinical trials involving nearly 50,000 participants. The independent Joint Committee on Vaccination and Immunisation will now consider whether to use the newly approved vaccine as part of the UK’s vaccination programme. We’ll keep you up to date on this and other developments, here on Care Radio.
Archbishop calls for society wide shift in support for unpaid carers
Adult social care workers urged to share Covid stories
Young Carers missing out on carer's allowance
20% increase in those at risk from type 2 diabetes
Black and ethnic minority people are underrepresented in virtual patient cohorts.
NHS dental treatment has still not returned to pre-pandemic levels
London councils object to relocation of specialist cancer service
West Lothian Council workers could trigger a summer of strike action
Care UK in Portsmouth to remember the hundreds of thousands of those who took part in D-Day
NHS and social care leaders could save £1 billion annually by adopting an AI-led home healthcare model
Software to reduce hospital waiting times will be rolled out across Scotland over the next year
No money for carers to get free public transport in Suffolk
Carer's Allowance overpayments affecting five thousand people in Northern Ireland
Information about insect bites and stings surges ahead of this bank holiday weekend
Skinny jabs like Ozempic are being used as a cop-out